PubRank

T Higenbottam

Author PubWeight™ 119.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996 11.76
2 Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995 7.03
3 Caution with use of inhaled nitric oxide. Lancet 1996 3.87
4 Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000 2.82
5 A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993 2.69
6 Angiotensin-converting enzyme and the cough reflex. Lancet 1987 1.94
7 Bronchial disease in ulcerative colitis. Thorax 1980 1.72
8 Heart-lung transplantation for cystic fibrosis. Lancet 1988 1.70
9 Cigarettes, lung cancer, and coronary heart disease: the effects of inhalation and tar yield. J Epidemiol Community Health 1982 1.68
10 Safety guidelines for use of nitric oxide. Lancet 1992 1.62
11 The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest 1990 1.60
12 Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J (Clin Res Ed) 1982 1.59
13 Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984 1.59
14 Plasma concentrations of lignocaine during fibreoptic bronchoscopy. Thorax 1982 1.52
15 Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet 1980 1.50
16 High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med 1992 1.48
17 Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993 1.47
18 Heart and lung transplantation in patients with end stage lung disease. Br Med J (Clin Res Ed) 1987 1.37
19 Measurement of exhaled nitric oxide in man. Thorax 1993 1.35
20 Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet 1994 1.22
21 Carbon monoxide yield of cigarettes and its relation to cardiorespiratory disease. Br Med J (Clin Res Ed) 1983 1.16
22 Selection and procurement of combined heart and lung grafts for transplantation. J Thorac Cardiovasc Surg 1988 1.14
23 Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis 1989 1.11
24 Narrowing of glottis opening in humans associated with experimentally induced bronchoconstriction. J Appl Physiol Respir Environ Exerc Physiol 1980 1.10
25 International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 1998 1.08
26 Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005 1.08
27 Exhaled nitric oxide in isolated pig lungs. J Appl Physiol (1985) 1995 1.07
28 Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant 1994 1.06
29 Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol 1994 1.05
30 The importance of cytomegalovirus in heart-lung transplant recipients. Chest 1989 1.04
31 Heart-lung transplantation: better use of resources. Am J Med 1988 1.02
32 UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997 1.01
33 Inhibition of artificially induced cough in man by bronchodilators. Br J Clin Pharmacol 1987 1.00
34 Successful heart-lung transplantation for cystic fibrosis. Chest 1988 0.99
35 Glottis narrowing in lung disease. Am Rev Respir Dis 1982 0.99
36 Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients. Am Rev Respir Dis 1990 0.98
37 Absence of electrochemical defect of cystic fibrosis in transplanted lung. Lancet 1987 0.98
38 Antitussive properties of inhaled bronchodilators on induced cough. Chest 1988 0.96
39 The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level. Eur Respir J 2008 0.95
40 New therapies for primary pulmonary hypertension. Chest 1994 0.93
41 The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996 0.93
42 Cough associated with angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 1989 0.93
43 Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis. Thorax 1991 0.92
44 A method for standardizing airway resistance for variations in lung volume. Clin Sci (Lond) 1979 0.92
45 International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Heart Lung 1998 0.91
46 Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 1993 0.91
47 Abdominal wall movement in normals and patients with hemidiaphragmatic and bilateral diaphragmatic palsy. Thorax 1977 0.91
48 International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998 0.91
49 Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. QJM 1994 0.90
50 Variable intrathoracic airways obstruction masquerading as asthma. Br Med J (Clin Res Ed) 1983 0.89
51 Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1991 0.88
52 Pulmonary epithelial permeability after inhaling saline, distilled water "fog" and cold air. Chest 1985 0.88
53 Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant 1992 0.88
54 The role of physiological deadspace and shunt in the gas exchange of patients with pulmonary hypertension: a study of exercise and prostacyclin infusion. Eur Respir J 1988 0.88
55 The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pract 1990 0.86
56 Lung Transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant 1996 0.86
57 Acute renal failure from the use of acetazolamide (Diamox). Postgrad Med J 1978 0.86
58 The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol 1994 0.86
59 Giving up smoking. Thorax 1984 0.85
60 Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Chest 1989 0.84
61 Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest 2001 0.83
62 Low dose infusion of atrial natriuretic peptide causes salt and water excretion in normal man. Clin Sci (Lond) 1988 0.82
63 Nitric oxide yields of contemporary UK, US and French cigarettes. Int J Epidemiol 1987 0.82
64 Cough induced by changes of ionic composition of airway surface liquid. Bull Eur Physiopathol Respir 1985 0.82
65 Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension. Thorax 1996 0.82
66 A comparison of exercise, hyperventilation with cold air and warm air, and the inhalation of "fog" in the provocation of asthma. Eur J Respir Dis Suppl 1983 0.82
67 The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am Rev Respir Dis 1987 0.81
68 Primary pulmonary hypertension. Br Med J (Clin Res Ed) 1986 0.81
69 Distant procurement of organs for clinical heart-lung transplantation using a single flush technique. Transplantation 1987 0.81
70 Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Am J Respir Crit Care Med 1997 0.81
71 Transplantation of the lungs and heart and lung for patients with severe pulmonary complications from sarcoidosis. Sarcoidosis 1990 0.80
72 The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation 1989 0.80
73 Early graft function following heart and lung transplantation. Transpl Int 1989 0.80
74 Pulmonary reflexes after human heart-lung transplantation. Respir Med 1991 0.80
75 Further clinical observations on the pulmonary effects of paraquat ingestion. Thorax 1979 0.79
76 Bronchial reactivity in asthmatic adults with normal spirometric values. Br Med J (Clin Res Ed) 1983 0.79
77 Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant 1989 0.79
78 Transplantation for end-stage lung disease. Respiration 1991 0.79
79 Successful use of repeated transbronchial lung biopsies in a patient with multiple opportunistic infections. Respir Med 1989 0.78
80 Acute effects of smoking a single cigarette on the airway resistance and the maximal and partial forced expiratory flow volume curves. Br J Dis Chest 1980 0.78
81 Practical importance of a preceding full inhalation or exhalation upon the measurement of airway resistance. Clin Sci (Lond) 1980 0.78
82 Influence of breath holding at total lung capacity on maximal expiratory flow measurements. Clin Sci (Lond) 1981 0.78
83 Cigarette smoke inhalation and the acute airway response. Thorax 1980 0.77
84 Inhaled nitric oxide: a magic bullet? Q J Med 1993 0.77
85 Nature and site of action of endogenous nitric oxide in vasculature of isolated pig lungs. J Appl Physiol (1985) 1997 0.77
86 Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome. Respiration 2001 0.76
87 Pulmonary hypertension. Br Med J (Clin Res Ed) 1987 0.75
88 Highlights on pulmonary hypertension: a commentary. Eur Respir J 1993 0.75
89 Transbronchial biopsy after lung transplantation. J Thorac Cardiovasc Surg 1991 0.75
90 Pulmonary hypertension, family and environment. J Hum Hypertens 1997 0.75
91 Lung transplantation and asthma. Lancet 1993 0.75
92 Single lung transplantation for end stage emphysema. Thorax 1995 0.75
93 Chondritis associated with fatal intramural bronchial fibrosis. Thorax 1979 0.75
94 Single lung transplantation and pulmonary hypertension. Br Heart J 1992 0.75
95 Intravenous epoprostenol for primary pulmonary hypertension. N Engl J Med 1996 0.75
96 Proteins of the respiratory tract after heart-lung transplantation. Transplantation 1990 0.75
97 Nitric oxide and exercise in the horse. J Physiol 1996 0.75
98 Airway complications after lung transplantation: is there a left-sided predilection? J Thorac Cardiovasc Surg 1995 0.75
99 International Primary Pulmonary Hypertension Study. Br Heart J 1994 0.75
100 Smoking in patients with advanced lung disease. Br Med J (Clin Res Ed) 1983 0.75
101 Clearance of inhaled 99mTc DTPA from regions of the lung recently affected by pulmonary embolus. Bull Eur Physiopathol Respir 1986 0.75
102 The molecular genetics of atopy. Ann Med 1991 0.75
103 Cardiopulmonary preservation. J Heart Transplant 1988 0.75
104 [Clinical applications of the heart-lung transplant. Clinical results 5 years after the start of the program at Papworth]. G Ital Cardiol 1989 0.75
105 [Heart-lung transplantation. Experience of Papworth Hospital. Apropos of 24 surgical cases]. Arch Mal Coeur Vaiss 1988 0.75
106 Ventilatory compensation for changes in posture after human heart-lung transplantation. Respir Physiol 1989 0.75
107 The role of nitric oxide in respiratory disease. Schweiz Med Wochenschr 1997 0.75
108 Heart-lung transplantation at Papworth Hospital. Eur J Cardiothorac Surg 1989 0.75
109 Daily cigarette consumption and lung function: a study of peak expiratory flow rates. Afr J Med Med Sci 1984 0.75
110 Asthma: an inherited dysfunction of bone marrow cells? Eur Respir J 1989 0.75
111 Lack of effect of nitric oxide inhibition on bronchial tone and methacholine-induced bronchoconstriction in man. Respir Med 1997 0.75
112 Heart-lung transplantation: graft function postoperatively. Transplant Proc 1990 0.75
113 The influence of controlled release theophylline on cold air induced bronchoconstriction in asthma. Br J Clin Pract Suppl 1984 0.75
114 Inhalation challenge testing for asthma. Role of bronchial provocation tests in clinical practice. Postgrad Med 1984 0.75
115 Do the oxides of nitrogen in cigarette smoke cause emphysema in smokers? Tokai J Exp Clin Med 1985 0.75
116 Early graft function after heart-lung transplantation. J Heart Transplant 1991 0.75
117 Methemoglobin levels in smokers and non-smokers. Arch Environ Health 1986 0.75
118 Role of prostacyclin in the treatment of primary pulmonary hypertension. Am J Cardiol 1995 0.75
119 Evaluation of the International Society for Heart Transplantation (ISHT) grading of pulmonary rejection in 100 consecutive biopsies. Transpl Int 1992 0.75
120 Respiratory activity of the vocal cords in normal subjects and patients with airflow obstruction: an electromyographic study. Clin Sci (Lond) 1981 0.75
121 Who waits longest for heart and lung transplantation? J Heart Lung Transplant 1994 0.75
122 Heart-lung transplantation in children. Transplant Proc 1990 0.75
123 Distant procurement and preservation of heart-lung homografts. Transplant Proc 1987 0.75
124 Tobacco smoking and the pulmonary surfactant system. Tokai J Exp Clin Med 1985 0.75
125 Late pulmonary haemodynamic changes in heart-lung transplantation. Eur Heart J 1992 0.75
126 Responses to cigarettes of various tar contents. Br J Dis Chest 1982 0.75
127 The characteristic histological changes associated with rejection in heart-lung transplant recipients. Transplant Proc 1989 0.75
128 Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant 1990 0.75
129 Management of heart-lung transplant patients. Verh Dtsch Ges Inn Med 1990 0.75
130 Developments in inhaled immunosuppressive therapy for the prevention of pulmonary graft rejection. BioDrugs 1998 0.75
131 Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation. Transpl Int 1996 0.75
132 Value of culture of biopsy material in diagnosis of viral infections in heart-lung transplant recipients. Transplant Proc 1990 0.75
133 Controlled-release theophylline in the treatment of nocturnal asthma. J Int Med Res 1990 0.75